Johnson & Johnson (JNJ) - Medical Equipment - Deals and Alliances Profile

Size: px
Start display at page:

Download "Johnson & Johnson (JNJ) - Medical Equipment - Deals and Alliances Profile"

Transcription

1 Johnson & Johnson (JNJ) - Medical Equipment - Deals and Alliances Profile

2 Johnson & Johnson (JNJ) - Medical Equipment - Deals and Alliances Profile BioPortfolio has been marketing business and market research reports from selected publishers for over fifteen years. BioPortfolio offers a personal service to our customers with dedicated research managers who will work with you to source the best report for your needs. Based in the UK, BioPortfolio is well positioned to coordinate our customers' orders sourced from over 50 global report publishers. We are pleased to present details of this report to assist your buying decision and administrative process. You will find easy-to-use How To Buy information on the last page of this document. We look forward to being of service to you. If you have bulk and/or recurring requirements, please get in touch - we can liaise with publishers to obtain sample pages and negotiate discounts on your behalf. Phone: +44 (0) or 2

3 Johnson & Johnson (JNJ) - Medical Equipment - Deals and Alliances Profile Summary Johnson & Johnson (J&J) is a pharmaceutical holding company. It carries out the manufacture and sale of a wide range of pharmaceutical products and medical devices. It provides products for human health and well-being. J&J s product offerings include consumer products comprising a wide range of health and personal care products in the beauty, skin care, nutritional, oral care, baby care, women s health and over-the-counter, and wellness and prevention categories; pharmaceuticals products to treat disorders related to hematology, neurology, oncology, immunology, infectious diseases, pain management and contraception, besides gastrointestinal conditions, infection, psychotic disorders and thrombosis; and medical devices and diagnostics for people suffering from some of the most widespread and chronic conditions. J&J is headquartered in New Brunswick, New Jersey, the US. The company aims to grow through strategic acquisitions. It also collaborates and partners with other companies and academic institutions for research, development and innovation. Johnson & Johnson (JNJ) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions. GlobalData derived the data presented in this report from proprietary in-house Medical etrack deals database, and primary and secondary research. Scope - Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company s (major public companies) key financial metrics and ratios. 3

4 - Business Description - A brief description of the company's operations. - Key Employees - A list of the key executives of the company. - Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company. - Key Competitors - A list of the key competitors of the company. - Key Recent Developments - A brief on recent news about the company. Reasons to Buy Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements - The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion / divestiture strategy - The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios. Equip yourself with detailed information about the company s operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors. Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Note*: Some sections may be missing if data is unavailable for the company. Additional Details Publisher : Global Data Reference : GDME659D 4

5 Number of Pages : 190 Report Format : PDF Publisher Information : 5

6 Table Of Contents for Johnson & Johnson (JNJ) - Medical Equipment - Deals and Alliances Profile Table of Contents Table of Contents 2List of Tables 6List of Figures 9Johnson & Johnson, Medical Equipment, Deals By Year, 2010 to YTD Johnson & Johnson, Medical Equipment Deals By Type, 2010 to YTD Johnson & Johnson, Medical Equipment, Deals By Region, 2010 to YTD Johnson & Johnson, Medical Equipment, Deals By Market, 2010 to YTD Johnson & Johnson, Medical Equipment, Deals Summary, 2010 to YTD Johnson & Johnson, Medical Equipment, Deal Details 22Asset Purchase 22Ethicon Acquires Quill Intellectual Property From Angiotech Pharma For Up To US$62 Million 22Venture Financing 23Clarimedix Raises Financing From COSAT 23Olive Medical Secures US$1 Million In Venture Financing 24Calibra Medical Secures US$7.1 Million In Financing Round 25Calibra Medical Secures US$1 Million In Venture Financing Round 26Calibra Medical Secures US$9.3 Million In Financing Round 27Private Equity 28Carlyle Group Completes Acquisition of Ortho-Clinical Diagnostics from Johnson & Johnson for up to USD4 Billion 28Water Street Healthcare Partners Acquires OraPharma 30Great Hill Partners And Primus Capital Complete The Acquisition Of SterilMed 31Partnerships 32KFx Medical Enters into Licensing Agreement with DePuy Mitek 32NanoPass Technologies Enters Into Licensing Agreement With Janssen Pharma For MicronJet 33Anika Therapeutics Enters Into Licensing Agreement With DePuy Mitek 34CJPS Medical Enters Into Licensing Agreement With Independence Technology 35Kreatech Diagnostics Signs An Agreement With Veridex 36Ethicon Endo-Surgery Enters Into Cross-Licensing Agreement With Hologic 37Janssen Pharma Enters into Agreement with Cue 38Ethicon Endo-Surgery Enters into Agreement with HistoSonics 39Medos International Enters into Agreement with Rainbow Medical 40Biosense Webster Enters into Agreement with Northwestern University 41Johnson & Johnson Forms Joint Venture with Google Life Sciences 42DePuy Synthes Enters into Agreement with Radlink 44Royal Philips Enters into Co-Development Agreement with Janssen Pharma 45Mitsubishi Tanabe Enters into Co-Promotion Agreement with Johnson & Johnson K.K. 46DePuy Synthes Enters into Co-Marketing Agreement with Blue Belt for Navio System 47Illumina Partners with AstraZeneca, Janssen and Sanofi to Develop NGS-Based Oncology Test System 48Tissue Regeneration Systems Enters into Co-Development Agreement with DePuy Synthes Products and Johnson & Johnson Innovation 50BrainStem Biometrics Systems Enters into Research Agreement with Ethicon Endo-Surgery 51DePuy Orthopaedics Enters Into Licensing Agreement With LifeNet Health For Cellular Allograft Product 52Adaptive Biotech Enters Into Biomarker Discovery Agreement With Johnson & Johnson Innovation 53Myriad Enters Into Research Agreement With Janssen Research & Development 54DePuy Synthes Expands Co-Marketing Agreement With Brainlab 55Coherex Medical Enters Into Distribution Agreement With Biosense Webster 56Janssen Pharmaceutica Enters Into Co-Development Agreement With Siemens Healthcare Diagnostics 57Arno Therapeutics Enters Into Co-Development Agreement With Veridex For Diagnostic Test 58OICR Enters Into Co-Development Agreement With Janssen For Prostate Cancer Biomarkers 59Abbott Molecular Enters Into Agreement With Janssen Biotech And Pharmacyclics For Leukemia Test 60Philips Enters Into Technology Integration Agreement With Biosense Webster 61DePuy Spine Enters Into Integration Agreement With Brainlab For Surgical And Imaging Solutions 62West Pharma Enters Into Co-Development Agreement With Janssen Biotech 63Biosense Webster Enters Into Technology Integration Agreement With GE Healthcare Systems And Siemens Healthcare 64Insulet Enters Into Technology Integration Agreement With LifeScan 65Biosense Webster Enters Into Distribution Agreement With GE Healthcare Systems 66Conceptus Terminates Co-Marketing Agreement With Ethicon 67Cellnovo Enters Into Technology Integration Agreement With LifeScan 68Skyline Diagnostics Enters Into Research Collaboration With Johnson & Johnson Pharma 69Life Technologies, Oxford Biomedical Research Centre, AstraZeneca And ORD Enter Into Co-Development Agreement 70Synthes Enters Into Co-Development Agreement With Eli Lilly 71LifeScan Terminates Distribution Agreement With Medtronic 72Stereotaxis Enters Into An Agreement With Biosense Webster 73Synthes Enters Into An Agreement With Materialise 74Sermo Enters Into Co-Development Agreement With Janssen Global Services 75Biocartis Enters Into Co-Development Agreement With Janssen Pharmaceutica 76Veridex Enters Into Co-Development Agreement With Massachusetts General Hospital 77Stereotaxis Amends Co-Development Agreement With Biosense Webster 78Janssen Pharmaceutica Enters Into Research Agreement With GE Healthcare 79Conceptus Enters Into Agreement With Ethicon 80Osseon Therapeutics Enters Into Distribution Agreement With DePuy Spine 81DePuy Spine Enters Into An Agreement With BrainLAB 82Laboratorios Farmaceuticos ROVI Terminates Distribution Agreement With Perouse Plastie 83Juvenile Diabetes Research Foundation Enters into Co-Development Agreement with Animas 84Cenix BioScience Enters Into Licensing Agreement With Janssen 85Advanced Biological Labs Enters Into Licensing 6

7 Agreement With Virco 86Debt Offering 87Johnson & Johnson Completes Public Offering Of Notes Due 2043 For US$500 Million 87Johnson & Johnson Completes Public Offering Of Notes Due 2016 For US$800 Million 89Johnson & Johnson Completes Public Offering Of Notes Due 2018 For US$600 Million 91Johnson & Johnson Completes Public Offering Of Notes Due 2016 For US$400 Million 93Johnson & Johnson Completes Public Offering Of Notes Due 2023 For US$550 Million 95Johnson & Johnson Completes Public Offering Of Notes Due 2033 For US$650 Million 97Johnson & Johnson Completes Public Offering Of Senior Unsecured Notes Due 2016 For US$900 Million 99Johnson & Johnson Completes Public Offering Of 0.70% Senior Unsecured Notes Due 2013 For US$500 Million 101Johnson & Johnson Completes Public Offering Of Senior Unsecured Notes Due 2041 For US$300 Million 103Johnson & Johnson Completes Public Offering Of Senior Unsecured Notes Due 2013 For US$500 Million 105Johnson & Johnson Completes Public Offering Of Senior Unsecured Notes Due 2021 For US$450 Million 107Johnson & Johnson Completes Public Offering Of Senior Unsecured Notes Due 2014 For US$1,000 Million 109Johnson & Johnson Completes Public Offering Of Senior Unsecured Notes Due 2014 For US$750 Million 111Johnson & Johnson Completes Offering Of 2.95% Notes Due 2020 For US$550 Million 113Johnson & Johnson Completes Offering Of 4.5% Notes Due 2040 For US$550 Million 115Asset Transactions 117Laboratorios Farmaceuticos ROVI to Acquire Injectables Production Plant from Crucell Spain for USD4.4 Million 117Biomet Completes Acquisition Of Trauma Business Of Depuy Orthopaedics For US$280 Million 118Johnson & Johnson To Sell Distal Volar Radius System To Biomet 119Symmetry Medical Completes Acquisition Of Surgical Instruments Business From Codman & Shurtleff For US$165 Million 120Ethicon Endo- Surgery Completes Sale Of Breast Care Business To Devicor Medical Products 122Acquisition 123Johnson & Johnson May Acquire Transenterix 123Biosense Webster Acquires Coherex Medical 124Cardinal Health Acquires Cordis from Johnson & Johnson for USD1.94 Billion 125DePuy Synthes Acquires Olive Medical 127Johnson & Johnson Plans to Acquire Cardiovascular Company 128Abbott, Johnson & Johnson And Sanofi Mull Individual Acquisition Of Bausch & Lomb 129Johnson & Johnson Acquires Spectrum Vision, Contact Lens Distributor 131LifeScan Acquires Calibra Medical 132Johnson & Johnson Completes Acquisition Of Synthes For US$19.7 Billion 133Johnson & Johnson (China) Acquires Guangzhou Bioseal Biotech 136Ethicon Endo-Surgery Completes Acquisition Of SterilMed From Great Hill Partners And Primus Capital 137Johnson & Johnson Plans To Acquire Manufacturer Of Heart Valves And Pumps 139Kensey Nash Acquires Norian From Synthes 140Johnson & Johnson May Acquire Medical Device And Diagnostics Companies 142Synthes Acquires The Anspach Effort 143Johnson & Johnson Completes Acquisition Of Micrus Endovascular 144Ethicon Completes Acquisition Of Acclarent 146Johnson & Johnson - Key Competitors 148Key Employees 149Locations And Subsidiaries 151Head Office 151Other Locations & Subsidiaries 151Recent Developments 169Strategy And Business Planning 169Jan 25, 2016: AstraZeneca partners with peers and academia to establish translational research fund 169Aug 27, 2015: Governor Scott Announces Johnson & Johnson s Creation Of 500 New Jobs In Tampa 170May 07, 2015: Johnson & Johnson Announces NYU School of Medicine Partnership To Evaluate Compassionate Use of Investigational Medicines 171Financial Announcements 172Jan 26, 2016: Johnson & Johnson Reports 2015 Fourth-Quarter Results 172Jul 14, 2015: Johnson & Johnson Reports 2015 Second- Quarter Results 174Apr 14, 2015: Johnson & Johnson Reports 2015 First-Quarter Results 176Feb 17, 2015: Johnson & Johnson Settles Over 100 Transvaginal Mesh Tape and Sling Cases 178Jan 20, 2015: Johnson & Johnson Reports 2014 Fourth-Quarter and Full-Year Results 179Corporate Communications 181Jan 19, 2016: Johnson & Johnson Announces Actions To Strengthen Medical Devices Leadership Position In Evolving Healthcare Marketplace 181Oct 21, 2015: Head Janssen Neuroscientist Appointed to Scientific Advisory Board of Global Dementia Discovery Fund 182Jun 09, 2015: CEO and Director of Huntsman Cancer Institute Dr. Mary Beckerle Joins Johnson & Johnson Board of Directors 183Legal and Regulatory 184Feb 03, 2016: Breaking News from Legal-Bay: Johnson & Johnson Settles for $120MM in First Big Transvaginal Mesh Settlement 184Oct 08, 2015: Robins Kaplan LLP Named Co-Lead Counsel in Disposable Contact Lens Antitrust Litigation 185Sep 29, 2015: Johnson & Johnson's Ethicon Wants Transvaginal Mesh $1.2MM Verdict Thrown Out, says Legal-Bay Lawsuit Settlement Funding 186Apr 21, 2015: Decision Diagnostics Shrugs Off New Attack As Johnson & Johnson Panics In Patent Case 187Feb 17, 2015: Boston Scientific Announces Agreement With Johnson & Johnson To Resolve Guidant Litigation 188Other Significant Developments 189Jun 18, 2015: Emulate Announces Strategic Collaboration with Johnson & Johnson Innovation to Use Organs-on-Chips Platform to Better Predict Human Response in Drug Development Process 189Appendix 190Methodology 190About GlobalData 190Contact Us 190Disclaimer 190 7

8 List Of Tables in Johnson & Johnson (JNJ) - Medical Equipment - Deals and Alliances Profile List of Tables Johnson & Johnson, Medical Equipment, Key Facts, Johnson & Johnson, Medical Equipment, Deals Summary, 2010 to YTD Johnson & Johnson, Medical Equipment, Deals By Year, 2010 to YTD Johnson & Johnson, Medical Equipment Deals By Type, 2010 to YTD Johnson & Johnson, Medical Equipment, Deals By Region, 2010 to YTD Johnson & Johnson, Deals By Market, 2010 to YTD Johnson & Johnson, Medical Equipment, Deals Summary, 2010 to YTD Ethicon Acquires Quill Intellectual Property From Angiotech Pharma For Up To US$62 Million 22 Clarimedix Raises Financing From COSAT 23 Olive Medical Secures US$1 Million In Venture Financing 24 Calibra Medical Secures US$7.1 Million In Financing Round 25 Calibra Medical Secures US$1 Million In Venture Financing Round 26 Calibra Medical Secures US$9.3 Million In Financing Round 27 Carlyle Group Completes Acquisition of Ortho-Clinical Diagnostics from Johnson & Johnson for up to USD4 Billion 28 Water Street Healthcare Partners Acquires OraPharma 30 Great Hill Partners And Primus Capital Complete The Acquisition Of SterilMed 31 KFx Medical Enters into Licensing Agreement with DePuy Mitek 32 NanoPass Technologies Enters Into Licensing Agreement With Janssen Pharma For MicronJet 33 Anika Therapeutics Enters Into Licensing Agreement With DePuy Mitek 34 CJPS Medical Enters Into Licensing Agreement With Independence Technology 35 Kreatech Diagnostics Signs An Agreement With Veridex 36 Ethicon Endo-Surgery Enters Into Cross-Licensing Agreement With Hologic 37 Janssen Pharma Enters into Agreement with Cue 38 Ethicon Endo-Surgery Enters into Agreement with HistoSonics 39 Medos International Enters into Agreement with Rainbow Medical 40 Biosense Webster Enters into Agreement with Northwestern University 41 Johnson & Johnson Forms Joint Venture with Google Life Sciences 42 8

9 DePuy Synthes Enters into Agreement with Radlink 44 Royal Philips Enters into Co-Development Agreement with Janssen Pharma 45 Mitsubishi Tanabe Enters into Co-Promotion Agreement with Johnson & Johnson K.K. 46 DePuy Synthes Enters into Co-Marketing Agreement with Blue Belt for Navio System 47 Illumina Partners with AstraZeneca, Janssen and Sanofi to Develop NGS-Based Oncology Test System 48 Tissue Regeneration Systems Enters into Co-Development Agreement with DePuy Synthes Products and Johnson & Johnson Innovation 50 BrainStem Biometrics Systems Enters into Research Agreement with Ethicon Endo-Surgery 51 DePuy Orthopaedics Enters Into Licensing Agreement With LifeNet Health For Cellular Allograft Product 52 Adaptive Biotech Enters Into Biomarker Discovery Agreement With Johnson & Johnson Innovation 53 Myriad Enters Into Research Agreement With Janssen Research & Development 54 DePuy Synthes Expands Co-Marketing Agreement With Brainlab 55 Coherex Medical Enters Into Distribution Agreement With Biosense Webster 56 Janssen Pharmaceutica Enters Into Co-Development Agreement With Siemens Healthcare Diagnostics 57 Arno Therapeutics Enters Into Co-Development Agreement With Veridex For Diagnostic Test 58 OICR Enters Into Co-Development Agreement With Janssen For Prostate Cancer Biomarkers 59 Abbott Molecular Enters Into Agreement With Janssen Biotech And Pharmacyclics For Leukemia Test 60 Philips Enters Into Technology Integration Agreement With Biosense Webster 61 DePuy Spine Enters Into Integration Agreement With Brainlab For Surgical And Imaging Solutions 62 West Pharma Enters Into Co-Development Agreement With Janssen Biotech 63 Biosense Webster Enters Into Technology Integration Agreement With GE Healthcare Systems And Siemens Healthcare 64 Insulet Enters Into Technology Integration Agreement With LifeScan 65 Biosense Webster Enters Into Distribution Agreement With GE Healthcare Systems 66 Conceptus Terminates Co-Marketing Agreement With Ethicon 67 Cellnovo Enters Into Technology Integration Agreement With LifeScan 68 Skyline Diagnostics Enters Into Research Collaboration With Johnson & Johnson Pharma 69 Life Technologies, Oxford Biomedical Research Centre, AstraZeneca And ORD Enter Into Co-Development Agreement 70 Synthes Enters Into Co-Development Agreement With Eli Lilly 71 LifeScan Terminates Distribution Agreement With Medtronic 72 Stereotaxis Enters Into An Agreement With Biosense Webster 73 9

10 Synthes Enters Into An Agreement With Materialise 74 Sermo Enters Into Co-Development Agreement With Janssen Global Services 75 Biocartis Enters Into Co-Development Agreement With Janssen Pharmaceutica 76 Veridex Enters Into Co-Development Agreement With Massachusetts General Hospital 77 Stereotaxis Amends Co-Development Agreement With Biosense Webster 78 Janssen Pharmaceutica Enters Into Research Agreement With GE Healthcare 79 Conceptus Enters Into Agreement With Ethicon 80 Osseon Therapeutics Enters Into Distribution Agreement With DePuy Spine 81 DePuy Spine Enters Into An Agreement With BrainLAB 82 Laboratorios Farmaceuticos ROVI Terminates Distribution Agreement With Perouse Plastie 83 Juvenile Diabetes Research Foundation Enters into Co-Development Agreement with Animas 84 Cenix BioScience Enters Into Licensing Agreement With Janssen 85 Advanced Biological Labs Enters Into Licensing Agreement With Virco 86 Johnson & Johnson Completes Public Offering Of Notes Due 2043 For US$500 Million 87 Johnson & Johnson Completes Public Offering Of Notes Due 2016 For US$800 Million 89 Johnson & Johnson Completes Public Offering Of Notes Due 2018 For US$600 Million 91 Johnson & Johnson Completes Public Offering Of Notes Due 2016 For US$400 Million 93 Johnson & Johnson Completes Public Offering Of Notes Due 2023 For US$550 Million 95 Johnson & Johnson Completes Public Offering Of Notes Due 2033 For US$650 Million 97 Johnson & Johnson Completes Public Offering Of Senior Unsecured Notes Due 2016 For US$900 Million 99 Johnson & Johnson Completes Public Offering Of 0.70% Senior Unsecured Notes Due 2013 For US$500 Million 101 Johnson & Johnson Completes Public Offering Of Senior Unsecured Notes Due 2041 For US$300 Million 103 Johnson & Johnson Completes Public Offering Of Senior Unsecured Notes Due 2013 For US$500 Million 105 Johnson & Johnson Completes Public Offering Of Senior Unsecured Notes Due 2021 For US$450 Million 107 Johnson & Johnson Completes Public Offering Of Senior Unsecured Notes Due 2014 For US$1,000 Million 109 Johnson & Johnson Completes Public Offering Of Senior Unsecured Notes Due 2014 For US$750 Million 111 Johnson & Johnson Completes Offering Of 2.95% Notes Due 2020 For US$550 Million 113 Johnson & Johnson Completes Offering Of 4.5% Notes Due 2040 For US$550 Million 115 Laboratorios Farmaceuticos ROVI to Acquire Injectables Production Plant from Crucell Spain for USD4.4 Million 117 Biomet Completes Acquisition Of Trauma Business Of Depuy Orthopaedics For US$280 Million

11 Johnson & Johnson To Sell Distal Volar Radius System To Biomet 119 Symmetry Medical Completes Acquisition Of Surgical Instruments Business From Codman & Shurtleff For US$165 Million 120 Ethicon Endo-Surgery Completes Sale Of Breast Care Business To Devicor Medical Products 122 Johnson & Johnson May Acquire Transenterix 123 Biosense Webster Acquires Coherex Medical 124 Cardinal Health Acquires Cordis from Johnson & Johnson for USD1.94 Billion 125 DePuy Synthes Acquires Olive Medical 127 Johnson & Johnson Plans to Acquire Cardiovascular Company 128 Abbott, Johnson & Johnson And Sanofi Mull Individual Acquisition Of Bausch & Lomb 129 Johnson & Johnson Acquires Spectrum Vision, Contact Lens Distributor 131 LifeScan Acquires Calibra Medical 132 Johnson & Johnson Completes Acquisition Of Synthes For US$19.7 Billion 133 Johnson & Johnson (China) Acquires Guangzhou Bioseal Biotech 136 Ethicon Endo-Surgery Completes Acquisition Of SterilMed From Great Hill Partners And Primus Capital 137 Johnson & Johnson Plans To Acquire Manufacturer Of Heart Valves And Pumps 139 Kensey Nash Acquires Norian From Synthes 140 Johnson & Johnson May Acquire Medical Device And Diagnostics Companies 142 Synthes Acquires The Anspach Effort 143 Johnson & Johnson Completes Acquisition Of Micrus Endovascular 144 Ethicon Completes Acquisition Of Acclarent 146 Johnson & Johnson, Key Competitors 148 Johnson & Johnson, Key Employees 149 Johnson & Johnson, Subsidiaries

12 List Of Figures, Charts and Diagrams in Johnson & Johnson (JNJ) - Medical Equipment - Deals and Alliances Profile List of Figures Johnson & Johnson, Medical Equipment, Deals by Type, 2010 to YTD Johnson & Johnson, Medical Equipment, Deals By Year, 2010 to YTD Johnson & Johnson, Medical Equipment, Deals By Region, 2010 to YTD Johnson & Johnson, Medical Equipment, Deals By Market, 2010 to YTD Johnson & Johnson, Medical Equipment, Deals By Year, 2010 to YTD Johnson & Johnson, Medical Equipment, Deals by Type, 2010 to YTD Johnson & Johnson, Medical Equipment, Deals By Region, 2010 to YTD Johnson & Johnson, Medical Equipment, Deals by Market, 2010 to YTD

13 How to Buy... Johnson & Johnson (JNJ) - Medical Equipment - Deals and Alliances Profile Option 1 - Online Go to our website and pay online with any major debit or credit card: Option 2 - Request a Proforma Invoice Fill in the details below, and either Scan this page and it to us at or Fax it to us at +44 (0) We will send you a Proforma Invoice and deliver your report on settlement. Your Name: Job Title: Your Your Contact Phone: Company Name: Address: Post/Zip Code: Country: P.O. Number: Any Other Instructions: Pricing Options: (please tick one) $250 Single User Price $500 Site License Price $750 Enterprise License Price Payment Options: (please tick one) Online Credit Card (we will you the invoice with a payment link) Direct Wire Transfer (we will you the invoice with our bank details) Authorising Signature: Option 3 - Phone Us on +44 (0) We will be delighted to give you our personal attention. 13

Mesa Laboratories, Inc. (MLAB) - Medical Equipment - Deals and Alliances Profile

Mesa Laboratories, Inc. (MLAB) - Medical Equipment - Deals and Alliances Profile Mesa Laboratories, Inc. (MLAB) - Medical Equipment - Deals and Alliances Profile Mesa Laboratories, Inc. (MLAB) - Medical Equipment - Deals and Alliances Profile BioPortfolio has been marketing business

More information

ConvaTec Group Plc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

ConvaTec Group Plc - Pharmaceuticals & Healthcare - Deals and Alliances Profile ConvaTec Group Plc - Pharmaceuticals & Healthcare - Deals and Alliances Profile ConvaTec Group Plc - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing business

More information

Nektar Therapeutics (NKTR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Nektar Therapeutics (NKTR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Nektar Therapeutics (NKTR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Nektar Therapeutics (NKTR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing

More information

North China Pharmaceutical Group Corp. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

North China Pharmaceutical Group Corp. - Pharmaceuticals & Healthcare - Deals and Alliances Profile North China Pharmaceutical Group Corp. - Pharmaceuticals & Healthcare - Deals and Alliances Profile North China Pharmaceutical Group Corp. - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio

More information

Bionure Farma SL - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Bionure Farma SL - Pharmaceuticals & Healthcare - Deals and Alliances Profile Bionure Farma SL - Pharmaceuticals & Healthcare - Deals and Alliances Profile Bionure Farma SL - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing business and

More information

Starpharma Holdings Limited (SPL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Starpharma Holdings Limited (SPL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Starpharma Holdings Limited (SPL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Starpharma Holdings Limited (SPL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio

More information

Starpharma Holdings Limited (SPL) - Medical Equipment - Deals and Alliances Profile

Starpharma Holdings Limited (SPL) - Medical Equipment - Deals and Alliances Profile Starpharma Holdings Limited (SPL) - Medical Equipment - Deals and Alliances Profile Starpharma Holdings Limited (SPL) - Medical Equipment - Deals and Alliances Profile BioPortfolio has been marketing business

More information

Acadia Pharmaceuticals Inc. (ACAD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Acadia Pharmaceuticals Inc. (ACAD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Acadia Pharmaceuticals Inc. (ACAD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Acadia Pharmaceuticals Inc. (ACAD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio

More information

DNA2.0 Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

DNA2.0 Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile DNA2.0 Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile DNA2.0 Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing business and market research

More information

Emcure Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Emcure Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile Emcure Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile Emcure Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing

More information

Mesa Laboratories, Inc. (MLAB) - Medical Equipment - Deals and Alliances Profile

Mesa Laboratories, Inc. (MLAB) - Medical Equipment - Deals and Alliances Profile Mesa Laboratories, Inc. (MLAB) - Medical Equipment - Deals and Alliances Profile Mesa Laboratories, Inc. (MLAB) - Medical Equipment - Deals and Alliances Profile BioPortfolio has been marketing business

More information

Vanderbilt University - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Vanderbilt University - Pharmaceuticals & Healthcare - Deals and Alliances Profile Vanderbilt University - Pharmaceuticals & Healthcare - Deals and Alliances Profile Vanderbilt University - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sector Publishing Intelligence Limited

More information

Collegium Pharmaceutical Inc (COLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Collegium Pharmaceutical Inc (COLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Collegium Pharmaceutical Inc (COLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Collegium Pharmaceutical Inc (COLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile The Business

More information

Median Kliniken GmbH & Co. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Median Kliniken GmbH & Co. - Pharmaceuticals & Healthcare - Deals and Alliances Profile Median Kliniken GmbH & Co. - Pharmaceuticals & Healthcare - Deals and Alliances Profile Median Kliniken GmbH & Co. - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing

More information

Natera, Inc. (NTRA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Natera, Inc. (NTRA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Natera, Inc. (NTRA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Natera, Inc. (NTRA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing business

More information

Karo Pharma AB (KARO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Karo Pharma AB (KARO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Karo Pharma AB (KARO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Karo Pharma AB (KARO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing business

More information

Bessemer Venture Partners - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Bessemer Venture Partners - Pharmaceuticals & Healthcare - Deals and Alliances Profile Bessemer Venture Partners - Pharmaceuticals & Healthcare - Deals and Alliances Profile Bessemer Venture Partners - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing

More information

Mindray Medical International Limited (MR) - Medical Equipment - Deals and Alliances Profile

Mindray Medical International Limited (MR) - Medical Equipment - Deals and Alliances Profile Mindray Medical International Limited (MR) - Medical Equipment - Deals and Alliances Profile Mindray Medical International Limited (MR) - Medical Equipment - Deals and Alliances Profile BioPortfolio has

More information

Glenmark Pharmaceuticals Inc., USA - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Glenmark Pharmaceuticals Inc., USA - Pharmaceuticals & Healthcare - Deals and Alliances Profile Glenmark Pharmaceuticals Inc., USA - Pharmaceuticals & Healthcare - Deals and Alliances Profile Glenmark Pharmaceuticals Inc., USA - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio

More information

Becton, Dickinson and Company (BDX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Becton, Dickinson and Company (BDX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Becton, Dickinson and Company (BDX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Becton, Dickinson and Company (BDX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio

More information

Bioton SA (BIO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Bioton SA (BIO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Bioton SA (BIO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Bioton SA (BIO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing business and market

More information

Faes Farma SA (FAE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Faes Farma SA (FAE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Faes Farma SA (FAE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Faes Farma SA (FAE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing business

More information

Pharmaxis Ltd (PXS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Pharmaxis Ltd (PXS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Pharmaxis Ltd (PXS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Pharmaxis Ltd (PXS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing business

More information

DaVita HealthCare Partners Inc. (DVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

DaVita HealthCare Partners Inc. (DVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile DaVita HealthCare Partners Inc. (DVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile DaVita HealthCare Partners Inc. (DVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sector

More information

Paramount Mining Corporation Limited (PCP) - Metals and Mining - Deals and Alliances Profile

Paramount Mining Corporation Limited (PCP) - Metals and Mining - Deals and Alliances Profile Paramount Mining Corporation Limited (PCP) - Metals and Mining - Deals and Alliances Profile Paramount Mining Corporation Limited (PCP) - Metals and Mining - Deals and Alliances Profile Sector Publishing

More information

The Walt Disney Company - Strategy, SWOT and Corporate Finance Report

The Walt Disney Company - Strategy, SWOT and Corporate Finance Report The Walt Disney Company - Strategy, SWOT and Corporate Finance Report The Walt Disney Company - Strategy, SWOT and Corporate Finance Report The Business Research Store is run by Sector Publishing Intelligence

More information

Vorwerk and Co. KG - Strategy, SWOT and Corporate Finance Report

Vorwerk and Co. KG - Strategy, SWOT and Corporate Finance Report Vorwerk and Co. KG - Strategy, SWOT and Corporate Finance Report Vorwerk and Co. KG - Strategy, SWOT and Corporate Finance Report The Business Research Store is run by Sector Publishing Intelligence Ltd.

More information

Gap, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Gap, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Gap, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Gap, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Sector Publishing Intelligence

More information

Compression Therapy - Medical Devices Pipeline Assessment, 2017

Compression Therapy - Medical Devices Pipeline Assessment, 2017 Compression Therapy - Medical Devices Pipeline Assessment, 2017 Compression Therapy - Medical Devices Pipeline Assessment, 2017 BioPortfolio has been marketing business and market research reports from

More information

Kohler Co. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Kohler Co. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Kohler Co. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Kohler Co. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Sector Publishing Intelligence

More information

McCain Foods Limited, Inc. - Strategic SWOT Analysis Review

McCain Foods Limited, Inc. - Strategic SWOT Analysis Review McCain Foods Limited, Inc. - Strategic SWOT Analysis Review McCain Foods Limited, Inc. - Strategic SWOT Analysis Review Sector Publishing Intelligence Limited (SPi) has been marketing business and market

More information

Surgical Sutures Market By Product Type [Automated Suturing Devices (Disposable Automated Suturing Devices, And Re-Usable Automated Suturing

Surgical Sutures Market By Product Type [Automated Suturing Devices (Disposable Automated Suturing Devices, And Re-Usable Automated Suturing Surgical Sutures Market By Product Type [Automated Suturing Devices (Disposable Automated Suturing Devices, And Re-Usable Automated Suturing Devices), and Sutures (Sutures by Type (Absorbable & Non-Absorbable),

More information

Phone: +44 (0) or BioPortfolio Limited

Phone: +44 (0) or   BioPortfolio Limited Global Laser Holographic Display Market by Product (Medical Scanners, Digital Signage, Kiosk, Notebook), by Application (Medical, Commercial, Industrial, Defense, Consumer Electronics), by Geography -

More information

Maruti Suzuki India Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Maruti Suzuki India Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Maruti Suzuki India Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Maruti Suzuki India Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment

More information

Critical Limb Ischemia - Pipeline Review, H1 2017

Critical Limb Ischemia - Pipeline Review, H1 2017 Critical Limb Ischemia - Pipeline Review, H1 2017 Critical Limb Ischemia - Pipeline Review, H1 2017 BioPortfolio has been marketing business and market research reports from selected publishers for over

More information

United States Sterilization Equipment Market Outlook to 2021

United States Sterilization Equipment Market Outlook to 2021 United States Sterilization Equipment Market Outlook to 2021 United States Sterilization Equipment Market Outlook to 2021 BioPortfolio has been marketing business and market research reports from selected

More information

WOLPERT ASSOCIATES, INC. Strategic Advisory Services Firm Overview

WOLPERT ASSOCIATES, INC. Strategic Advisory Services Firm Overview Strategic Advisory Services 2018 Firm Overview Our Foundational Principles Strategic Advice for Biopharmaceutical, Medical Technology and Life Science sectors A Focus on Strategic Thinking in the Context

More information

State of Licensing 2011 Update

State of Licensing 2011 Update State of Licensing 2011 Update Moderators/Speakers Hemmie Chang, Chair, Licensing & Strategic Alliance Practice Group, Foley Hoag LLP Ranya Dajani, Executive Director, Strategic Transactions Group, Bristol-

More information

PwC Deals $42B. Global Pharma & Life Sciences Deals Insights Q Update

PwC Deals $42B. Global Pharma & Life Sciences Deals Insights Q Update PwC Deals Q3 16 Update Executive summary Global Pharma and Life Sciences (PLS) deal activity declined both in volume and value this quarter compared to the prior quarter and Q3 15. The considerable decrease

More information

Implantable Drug Delivery Devices Market - Global Industry Analysis, Size, Share, Trends And Forecast,

Implantable Drug Delivery Devices Market - Global Industry Analysis, Size, Share, Trends And Forecast, Transparency Market Research Implantable Drug Delivery Devices Market - Global Industry Analysis, Size, Share, Trends And Forecast, 2012 2018 Buy Now Request Sample Published Date: Mar 2013 Single User

More information

Perspectives of Innovative Small Companies on the Industry s Prospects for 2012 and Beyond

Perspectives of Innovative Small Companies on the Industry s Prospects for 2012 and Beyond Perspectives of Innovative Small Companies on the Industry s Prospects for 2012 and Beyond ACI Forum on Structuring, Negotiating and Managing Life Sciences Collaborations and Acquisitions February 28,

More information

Generics Series: Authorized Generics Analysis Stemming the Generics Tide

Generics Series: Authorized Generics Analysis Stemming the Generics Tide Generics Series: Authorized Generics Analysis Stemming the Generics Tide Report summary An overview of the authorized generics landscape, including drivers and resistors for both branded and generics players

More information

Reinventing Invention: Advancing Collaboration for Sustainable Bioscience R&D

Reinventing Invention: Advancing Collaboration for Sustainable Bioscience R&D Reinventing Invention: Advancing Collaboration for Sustainable Bioscience R&D John C. Lechleiter, Ph.D. Chairman, President, and Chief Executive Officer Eli Lilly and Company Washington Biotechnology &

More information

Omeros Raises More Than $63 Million in Financing

Omeros Raises More Than $63 Million in Financing Omeros Raises More Than $63 Million in Financing Seattle, WA February 12, 2007 Omeros today announced that it has raised in excess of $63 million in an oversubscribed Series E equity financing. New investors,

More information

Dealdoc. Acquisition agreement for Gambro. Baxter International Gambro. Dec , Wildwood Ventures Ltd. All rights reserved.

Dealdoc. Acquisition agreement for Gambro. Baxter International Gambro. Dec , Wildwood Ventures Ltd. All rights reserved. Dealdoc Acquisition agreement for Gambro Baxter International Gambro Dec 04 2012 Acquisition agreement for Gambro Companies: Baxter International Gambro Announcement date: Dec 04 2012 Deal value, US$m:

More information

JOHN JACK R. TUPMAN, JR CURRICULUM VITAE

JOHN JACK R. TUPMAN, JR CURRICULUM VITAE JOHN JACK R. TUPMAN, JR CURRICULUM VITAE September 2018 John R. Tupman, Jr. is a consultant focused on business development and licensing in the life sciences industry. He is currently working as a consultant

More information

Fall State of the Industry Report UF SID MARTIN FLORIDA BIODATABASE

Fall State of the Industry Report UF SID MARTIN FLORIDA BIODATABASE Fall 2015 State of the Industry Report UF SID MARTIN FLORIDA BIODATABASE Industry Overview The expansion of Florida s biotech industry remains resilient with an overall growth rate of 92% in the number

More information

AMCo current. Medpace new in Sebia realised. Spire Healthcare partially realised. Healthcare. Sector insights. Our Healthcare portfolio in 2014

AMCo current. Medpace new in Sebia realised. Spire Healthcare partially realised. Healthcare. Sector insights. Our Healthcare portfolio in 2014 Sector insights The healthcare market is highly complex with global products delivered through local services and channels. The healthcare value chain is intricate, diverse and interdependent. It is a

More information

GLOBAL MARKETS AND TECHNOLOGIES FOR ADVANCED DRUG DELIVERY SYSTEMS

GLOBAL MARKETS AND TECHNOLOGIES FOR ADVANCED DRUG DELIVERY SYSTEMS GLOBAL MARKETS AND TECHNOLOGIES FOR ADVANCED DRUG DELIVERY SYSTEMS PHM006K March 2016 Himani Singhi Wadhwa Project Analyst ISBN: 1-62296-254-0 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481

More information

Roche's Global IP Strategy 10th. JIPA IP Symposium, Tokyo Dr. Axel Braun F. Hoffmann La Roche Ltd.

Roche's Global IP Strategy 10th. JIPA IP Symposium, Tokyo Dr. Axel Braun F. Hoffmann La Roche Ltd. Roche's Global IP Strategy 10th. JIPA IP Symposium, Tokyo 2011 Dr. Axel Braun F. Hoffmann La Roche Ltd. Content Roche Company Profile The IP Department Patent Filings Global Strategy Sales Overview IP

More information

April By Type of Approach- Transfemoral and Transapical. By Region- North America, Europe, APAC and RoW

April By Type of Approach- Transfemoral and Transapical. By Region- North America, Europe, APAC and RoW Global Transcatheter Aortic Valve Replacement (TAVR) Market: Analysis By Type of Approach (Transfemoral and Transapical), By Region, By Country: Opportunities and Forecast (2017-2022) By Type of Approach-

More information

New York Bar admission (or eligibility to obtain admission promptly) is required.

New York Bar admission (or eligibility to obtain admission promptly) is required. Job Opportunities To apply to any of the positions send cover letter referencing job opening with resume and salary requirements to info@bryantrabbino.com Senior Level Corporate Finance Attorney We are

More information

Your Content Your Way

Your Content Your Way MY VIEW Your Content Your Way My View allows you to view only the topics you want to follow. Choose from a list of available topics, which are individualized for each publications, and design your own

More information

Goldman Sachs Medtech Conference, 9 September Dave Illingworth CEO

Goldman Sachs Medtech Conference, 9 September Dave Illingworth CEO Goldman Sachs Medtech Conference, 9 September Dave Illingworth CEO 0 Forward looking statements This presentation contains certain "forward-looking statements" within the meaning of the US Private Securities

More information

Aqua Pharmaceuticals, LLC

Aqua Pharmaceuticals, LLC Aqua Pharmaceuticals, LLC Corporate Presentation June 2011 AQUA PHARMACEUTICALS, LLC 1 Company Overview Specialty dermatology pharmaceutical company currently focusing on acquiring, developing and marketing

More information

VALUATION TRENDS 18.8

VALUATION TRENDS 18.8 SPOT ON TESTING, INSPECTION & CERTIFICATION Arjen Kostelijk, Oaklins' Testing, Inspection & Certification (TIC) specialist, is pleased to share some highlevel industry intelligence in this edition of Spot

More information

CeQur establishes Wales subsidiary

CeQur establishes Wales subsidiary FOR IMMEDIATE RELEASE CeQur establishes Wales subsidiary -- Arthurian Life Sciences investment helps bring to market world s first three-day simple insulin infusion device for type 2 diabetes -- LUCERNE,

More information

Mara H. Rogers, Partner Norton Rose Fulbright

Mara H. Rogers, Partner Norton Rose Fulbright Mara H. Rogers Partner Norton Rose Fulbright US LLP New York T:+1 212 318 3206 F:+1 212 318 3400 mara.rogers@nortonrosefulbright.com vcard (+Outlook) Related services Corporate, M&A and securities Mergers

More information

HBM Healthcare Investments Ltd Access to a Global and Diversified Private Equity Healthcare Portfolio

HBM Healthcare Investments Ltd Access to a Global and Diversified Private Equity Healthcare Portfolio HBM Healthcare Investments Ltd Access to a Global and Diversified Private Equity Healthcare Portfolio SECA conference Zurich, 3 July 2013 Dr. Andreas Wicki, CEO HBM at a Glance SIX-listed investment company

More information

Driving profitable growth in Greater China. Andy Ho Chief Market Leader Greater China

Driving profitable growth in Greater China. Andy Ho Chief Market Leader Greater China Driving profitable growth in Greater China Andy Ho Chief Market Leader Greater China Key takeaways China HealthTech market is the 2 nd largest globally and exhibits continued robust growth with significant

More information

Bayer Inc. Science for a Better Life. Talking with Phil Blake, President, Bayer Inc., HealthCare Representative and Head, Pharmaceuticals Division

Bayer Inc. Science for a Better Life. Talking with Phil Blake, President, Bayer Inc., HealthCare Representative and Head, Pharmaceuticals Division Bayer Inc. Science for a Better Life Talking with Phil Blake, President, Bayer Inc., HealthCare Representative and Head, Pharmaceuticals Division Please review your career path to date, leading to your

More information

A Brief Introduction to the Regulatory Environment of Medical Device Supervision. CFDA Department of Legal Affairs Liu Pei

A Brief Introduction to the Regulatory Environment of Medical Device Supervision. CFDA Department of Legal Affairs Liu Pei A Brief Introduction to the Regulatory Environment of Medical Device Supervision CFDA Department of Legal Affairs Liu Pei Development Trend of Medical Device Industry Development Opportunities of Medical

More information

Cautions Concerning Forward-looking Statements

Cautions Concerning Forward-looking Statements 1 Cautions Concerning Forward-looking Statements These presentations contain forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995 regarding, among other things,

More information

VentureSource Europe -- 3Q 2014

VentureSource Europe -- 3Q 2014 Europe -- 3Q 2014 The following report presents Dow Jones VentureSource s quarterly findings for European venture capital fundraising, investment, and liquidity. The included charts and graphs offer a

More information

Healthcare and Life Sciences

Healthcare and Life Sciences Healthcare and Life Sciences Introduction Uría Menéndez is an independent law firm that was founded in Madrid in 1946 by Professor Rodrigo Uría González. We currently have seventeen offices in Spain, Portugal,

More information

CHINA MED DEVICE. China Medtech Will Continue Its Double Digit Growth in Years to Come

CHINA MED DEVICE.   China Medtech Will Continue Its Double Digit Growth in Years to Come China Medtech Will Continue Its Double Digit Growth in Years to Come The high level characteristics of medtech in China is focused here. Each of the 6 specific sectors according to SWS recommendation will

More information

CASI Pharmaceuticals, Inc.

CASI Pharmaceuticals, Inc. CASI Pharmaceuticals, Inc. Your Strategic Drug Development Partner in China NASDAQ: CASI WWW.CASIPHARMACEUTIALS.COM Forward Looking Statements This presentation contains forward-looking statements within

More information

EXECUTIVE SUMMARY. Investment Opportunity. Paradox Financial Solutions Inc.

EXECUTIVE SUMMARY. Investment Opportunity. Paradox Financial Solutions Inc. An innovative new system for Supply Chain Financing that is so disruptive that it will revolutionize the way in which practices in B2B trading relationships occur. has invented a system that revolutionizes

More information

Cross-Border R&D in China Understanding the Regulatory Challenges

Cross-Border R&D in China Understanding the Regulatory Challenges 1 2 Cross-Border R&D in China Understanding the Regulatory Challenges 1 Panelists Moderator: Paul A. Stewart, Silicon Valley Office Managing Partner, Foley & Lardner LLP Speakers: David Rosen, Partner,

More information

Digital Health Funding and M&A

Digital Health Funding and M&A Digital Health Funding and M&A 2018 Third Quarter and Nine Month Report Funding and Merger & Acquisition activity for the Digital Health sector http://www.mercomcapital.com 1 Copyright 2010-2016 Mercom

More information

1 Table of Contents 1.1 List of Tables 1.2 List of Figures 2 Introduction 3 Global Neurostimulation Devices Market - An Overview 3.

1 Table of Contents 1.1 List of Tables 1.2 List of Figures 2 Introduction 3 Global Neurostimulation Devices Market - An Overview 3. 1 Table of Contents 1.1 List of Tables 1.2 List of Figures 2 Introduction 3 Global Neurostimulation Devices Market - An Overview 3.1 Spinal Cord Stimulator 3.2 Deep Brain Stimulator 3.3 Vagus Nerve Stimulator

More information

Digital Health Startups A FirstWord ExpertViews Dossier Report

Digital Health Startups A FirstWord ExpertViews Dossier Report AM PL E PA G ES S A G ES S A FirstWord ExpertViews Dossier Report Published Copyright 2016 Doctor s Guide Publishing Limited All rights reserved. No part of this publication may be reproduced or used in

More information

At the forefront of Abu Dhabi s economic diversification. August 2008

At the forefront of Abu Dhabi s economic diversification. August 2008 At the forefront of Abu Dhabi s economic diversification August 2008 Mubadala was established by the Government transformation of Abu Dhabi. to help drive the situation analysis 4 HIGH 3 Financial Return

More information

BOARD OF DIRECTORS. PETER WEHRLY Chair

BOARD OF DIRECTORS. PETER WEHRLY Chair BOARD OF DIRECTORS PETER WEHRLY Chair Peter Wehrly is the former group president of developed markets at Covidien, the manufacturer of medical devices with sales of over $10.7 billion (2014). Peter held

More information

Kandace P. Watson Partner

Kandace P. Watson Partner Kandace P. Watson Partner 12275 El Camino Real Suite 200 San Diego, CA 92130 T: 858.720.8930 F: 858.523.6770 kwatson@sheppardmullin.com Practices Healthcare Corporate Mergers and Acquisitions Technology

More information

For personal use only

For personal use only ASX ANNOUNCEMENT AGM PRESENTATION SYDNEY, Monday 21 November 2016: Cellmid Limited (ASX:CDY) provides the following presentation for the Annual General Meeting of the shareholders. End Contact: Maria Halasz,

More information

Daryn A. Grossman. Proskauer.com. Partner. New York

Daryn A. Grossman. Proskauer.com. Partner. New York Contact Daryn A. Grossman Partner New York +1.212.969.3665 dgrossman@proskauer.com Daryn A. Grossman is co-chair of Proskauer s global Corporate Department. She serves as the head of the Life Sciences

More information

Cannabis Practice Group

Cannabis Practice Group Cannabis Practice Group McMillan LLP Vancouver Calgary Toronto Ottawa Montréal Hong Kong Cannabis mcmillan.ca Practice Group 1 Medical cannabis is booming and McMillan is at the forefront of developments

More information

FDA Centers of Excellence in Regulatory and Information Sciences

FDA Centers of Excellence in Regulatory and Information Sciences FDA Centers of Excellence in Regulatory and Information Sciences February 26, 2010 Dale Nordenberg, MD novasano HEALTH AND SCIEN Discussion Topics Drivers for evolution in regulatory science Trends in

More information

Comprehensive Research Services

Comprehensive Research Services Comprehensive Research Services Scripps Health: At the Forefront of Clinical Research Scripps Health is a recognized leader in clinical research and has long been at the forefront of numerous medical breakthroughs.

More information

Venture Capital Report

Venture Capital Report Venture Capital Report Europe 3Q 2015 The following report presents Dow Jones VentureSource s quarterly findings for European venture capital fundraising, investment, valuation, and liquidity. The included

More information

Method of Declaration. Hospitality/Interest/Sponsorship

Method of Declaration. Hospitality/Interest/Sponsorship Hospitality/Interest/Sponsorship Date Received Method of Declaration Abbott Laboratories Limited 23/03/12 Sponsorship Abbott Laboratories Limited 28/05/12 Sponsorship Abbott Laboratories Limited 23/03/12

More information

Medtech Slowdown. Life sciences venture capital funding lagged behind other industries, declining 10% in 4Q13 and 1% in 2013 over last year

Medtech Slowdown. Life sciences venture capital funding lagged behind other industries, declining 10% in 4Q13 and 1% in 2013 over last year www.pwc.com Medtech Slowdown Life sciences venture capital funding lagged behind other industries, declining 10% in 4Q13 and 1% in 2013 over last year February 2014 2 PwC US venture capital funding for

More information

September 18, 2017 Special Called Meeting of the U. T. System Board of Regents - Meeting of the Board

September 18, 2017 Special Called Meeting of the U. T. System Board of Regents - Meeting of the Board AGENDA SPECIAL CALLED TELEPHONE MEETING of THE UNIVERSITY OF TEXAS SYSTEM BOARD OF REGENTS September 18, 2017 Austin, Texas Page CONVENE THE BOARD IN OPEN SESSION TO RECESS TO EXECUTIVE SESSION PURSUANT

More information

FS INVESTMENTS & KKR FORM STRATEGIC PARTNERSHIP. Combining FSIC & CCT platforms to create stockholder value

FS INVESTMENTS & KKR FORM STRATEGIC PARTNERSHIP. Combining FSIC & CCT platforms to create stockholder value FS INVESTMENTS & KKR FORM STRATEGIC PARTNERSHIP Combining FSIC & CCT platforms to create stockholder value FS INVESTMENTS AND KKR TO ESTABLISH INDUSTRY-LEADING PARTNERSHIP FS Investments ( FS ) and KKR

More information

ALANCO TECHNOLOGIES INC

ALANCO TECHNOLOGIES INC SECURITIES & EXCHANGE COMMISSION EDGAR FILING ALANCO TECHNOLOGIES INC Form: 8-K Date Filed: 2016-10-04 Corporate Issuer CIK: 98618 Copyright 2016, Issuer Direct Corporation. All Right Reserved. Distribution

More information

Data-Driven Evaluation: The Key to Developing Successful Pharma Partnerships

Data-Driven Evaluation: The Key to Developing Successful Pharma Partnerships R&D Solutions for PHARMA & LIFE SCIENCES DRUG DISCOVERY & DEVELOPMENT Data-Driven Evaluation: The Key to Developing Successful Pharma Partnerships Summary For pharmaceutical companies to succeed, it is

More information

THE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (EASTERN-EUROPE EDITION)

THE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (EASTERN-EUROPE EDITION) THE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (EASTERN-EUROPE EDITION) Feedback from 93 Eastern-European patient groups PUBLISHED JULY 2016 CONTENTS ABOUT THIS REPORT Page 1 WHAT DID

More information

Digitalization and TITLE OF. Devices May 2018 PRESENTATION

Digitalization and TITLE OF. Devices May 2018 PRESENTATION Digitalization and Globalization TITLE OF of Medical Devices May 2018 PRESENTATION R&D Spend (in Bn) Consolidated ER&D Spending : E-R&D spend is highly consolidated among top 5 OEMs; Imaging and Non-imaging

More information

Trends in Healthcare Investments and Exits 2018

Trends in Healthcare Investments and Exits 2018 Trends in Healthcare Investments and Exits 208 208 Massachusetts Life Science Innovation Day Clark Hayes Managing Director Life Science/Healthcare Northeast Head of Business Development SVB Corporate Overview

More information

Horizon Societal Challenge 1: Health, demographic change and wellbeing. Jeremy Bray DG Research & Innovation European Commission

Horizon Societal Challenge 1: Health, demographic change and wellbeing. Jeremy Bray DG Research & Innovation European Commission Horizon 2020 Societal Challenge 1: Health, demographic change and wellbeing Jeremy Bray DG Research & Innovation European Commission National NHS day Leeds, UK, 29 January 2014 What is Horizon 2020? The

More information

Intellectual property governance and strategic value creation:

Intellectual property governance and strategic value creation: Intellectual property governance and strategic value creation: some evidence from European organizations in, pharmaceutical and public research fields Dr. Federica Rossi (rossi.federica@unito.it) Universita

More information

Purvi B. Maniar Member of the Firm

Purvi B. Maniar Member of the Firm Purvi B. Maniar Member of the Firm New York 250 Park Avenue New York, New York 10177 Tel: 212-351-3757 Fax: 212-878-8600 St. Louis Tel: 314-395-2775 pmaniar@ebglaw.com PURVI B. MANIAR is a Member of the

More information

Seale & Associates Creative Solutions. Trusted Advice. MERGERS & ACQUISITIONS MEXICO JUNE 2018 MONTHLY ISSUE

Seale & Associates Creative Solutions. Trusted Advice. MERGERS & ACQUISITIONS MEXICO JUNE 2018 MONTHLY ISSUE MERGERS & ACQUISITIONS MEXICO JUNE 2018 MONTHLY ISSUE MERGERS & ACQUISITIONS IN MEXICO In June 2018, 15 transactions were announced in Mexico, a decrease of 21% over last month. Also, total reported deal

More information

Global Source Ventures, LLC Introduction. Antonius Schuh Managing Partner Stephen Zaniboni Managing Partner

Global Source Ventures, LLC Introduction. Antonius Schuh Managing Partner Stephen Zaniboni Managing Partner Global Source Ventures, LLC Introduction Antonius Schuh Managing Partner Stephen Zaniboni Managing Partner Introduction to Global Source Ventures GSV provides seed capital to emerging companies with emphasis

More information

January Bob DeSutter Managing Director Co-Head of Health Care

January Bob DeSutter Managing Director Co-Head of Health Care January 2007 Dear Friends and Clients, For much of our 112 year history, serving innovative health care companies has been an important part of our mission at Piper Jaffray. Our goal is to be lead advisor

More information

Life Sciences Outlook. New York City 2016

Life Sciences Outlook. New York City 2016 Life Sciences Outlook City 2016 City is emerging as a leading destination for biotech startups and the larger life sciences industry. Investors have committed millions of dollars throughout the city and

More information

How attractive is the BioRegion of Catalonia for foreign investment? Guy Nohra Co-Founder and Managing Director of Alta Partners

How attractive is the BioRegion of Catalonia for foreign investment? Guy Nohra Co-Founder and Managing Director of Alta Partners How attractive is the BioRegion of Catalonia for foreign investment? Guy Nohra Co-Founder and Managing Director of Alta Partners How attractive is the BioRegion of Catalonia for foreign investment? M ost

More information

Firm Overview. The firm includes 25 professionals, including 19 lawyers and 6 patent agents and technical specialists, of whom 10 hold Ph.D. degrees.

Firm Overview. The firm includes 25 professionals, including 19 lawyers and 6 patent agents and technical specialists, of whom 10 hold Ph.D. degrees. Firm Overview At Lahive, our thinking expands yours. Our lawyers and technical specialists practice at the cutting edge of intellectual property, with special expertise in biotechnology, chemistry, high

More information

Biotech Concerto #6 Investment Process December 2008

Biotech Concerto #6 Investment Process December 2008 Biotech Concerto #6 Investment Process December 2008 Index Biotech Investment Characteristics Investment Policy Investment Team Scientific Advisory Board Deal Flow Attrition Rate From Screening to Decision

More information